Pulmonx Corp reports results for the quarter ended in January 1 - Earnings Summary

Pulmonx

31/10/2024 03:05

* Pulmonx Corp  LUNG.OQ  reported a quarterly adjusted loss
of 36
cents​​ per share for the quarter ended January 1, higher than
the same quarter last year, when the company reported EPS of -39
cents.  The mean expectation of six analysts for the quarter was
for a loss of 45 cents per share. Wall Street expected
results to range from -49 cents to -43 cents per share.
    * Revenue rose 15.4% to $20.39 million from a year ago;
analysts
expected $20.29 million. 
    * Pulmonx Corp's reported EPS for the quarter was a loss
of 36
cents​.
    * The company reported a quarterly loss of $14.14 million.
    * Pulmonx Corp shares had fallen by 18.3% this quarter and
lost 46.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Pulmonx Corp is
$14.00 
This summary was machine generated from LSEG data October 31 at
03:05 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.45          -0.36          Beat
 Jun. 30 2024      -0.43          -0.35          Beat
 Mar. 31 2024      -0.46          -0.36          Beat
 Dec. 31 2023      -0.41          -0.36          Beat